Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity (Q28138211)
Jump to navigation
Jump to search
scientific article (publication date: December 2000)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity |
scientific article (publication date: December 2000) |
Statements
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity (English)
0 references
1 December 2000
0 references
165
0 references
11
0 references
6047-55
0 references